Expression in Pichia pastoris of a recombinant scFv form of MAb 107, an anti human CD11b integrin antibody

Enzyme and Microbial Technology

Volumn 38, Issue 5, 2006, Pages 636-642

  Tanfous, Naouel Guedel Ben ^a   Kallel, Héla ^a   Jarboui, M Ali ^a   Fathallah, Dahmani M ^a  

^a PASTEUR INSTITUTE OF TUNIS   (Tunisia)

Author keywords

Anti human integrin; Monoclonal antibody; Pichia pastoris; Taguchi experimental design

Indexed keywords

ADHESION; GENETIC ENGINEERING; IMMUNOLOGY; PH EFFECTS; YEAST;

ANTI HUMAN INTEGRIN; ANTI INFLAMMATORY ACTIVITIES; PICHIA PASTORIS; TAGUCHI EXPERIMENTAL DESIGNS;

MONOCLONAL ANTIBODIES;

CD11 ANTIGEN; CD11B ANTIGEN; CD18 ANTIGEN; HYBRID PROTEIN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 107; MYELOID DIFFERENTIATION FACTOR 88; RECOMBINANT ANTIBODY; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ANTIGEN PURIFICATION; ANTIINFLAMMATORY ACTIVITY; ARTICLE; DRUG BINDING; DRUG MECHANISM; DRUG SCREENING; PICHIA PASTORIS; PLASMID; PROTEIN DEGRADATION;

PICHIA PASTORIS;

EID: 30944448806     PISSN: 01410229     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.enzmictec.2005.07.014     Document Type: Article

References (23)

1. R. Li, I. Haruta, P. Rieu, T. Sugimori, J.P. Xiong, and M.A. Arnaout Characterization of a conformationally sensitive murine monoclonal antibody directed to the metal ion-dependent adhesion site face of integrin CD11b J Immunol 168 2002 1219 1225
2. D.L. Schawler, R.M. Bartholomew, L.M. Smith, and R.O. Dillman Human immune response to multiple injections of murine monoclonal IgG J Immunol 135 1985 1530 1535
3. R.W. Schroff, K.A. Foon, S.M. Beatty, R.K. Oldham, and A.C. Morgan Jr. Human anti-murine immunoglobulin responses in patients receiving monoclonal antibody therapy Cancer Res 45 1985 879 885
4. M. Afanasieva, M. Wittmer, A. Vitaliti, M. Ajmo, D. Neri, and R. Klemenz Single-chain antibody and its derivatives and directed against vascular endothelial growth factor: application for antiangiogenic gene therapy Gene Ther 10 2003 1850 1859
5. M. Azemar, S. Djahansouzi, E. Jager, C. Solbach, M. Schmidt, and A.B. Maurer Regression of cutaneous tumor lesions in patients intratumorally injected with a recombinant single chain antibody-toxin targeted to ErbB2/HER2 Breast Cancer Res Treat 82 2003 155 164
6. G. Gellissen Heterologous protein production in methylotrophic yeasts Appl Microbiol Biotechnol 54 2000 741 750
7. S. Lang, J. Schmitt, and R.D. Schmid High yield expression of the recombinant, atrazine-specific Fab fragment K411B by the methylotrophic yeast Pichia pastoris J Immunol Methods 255 2001 10 114
8. C. Gurkan, S.N. Symeonodes, and D.J. Ellar High-level production in Pichia pastoris of an anti-HER-2-scFv using an alternative secretion expression vector Biotechnol Appl Biochem 39 2004 115 122
9. G. Taguchi Introduction to quality engineering 1986 Asian productivity organisation, UNIPUB New York
10. L. Aujame, D. Seguin, C. Droy, and C. Hessler Experimental design optimisation of filamentous phage transfect mammalian cells by cationic lipids Biotechniques 28 2000 1202 1208
11. J.J. Han, T.H. Yang, and J.S. Rhee Optimisation of reaction variables for sucrose monoester production using lipase in solvent free system by Taguchi's method Techniques 12 1998 295 299
12. B.D. Cobb, and J.M. Clarkson A simple procedure for optimisation the polymerase chain reaction (PCR) using modified Taguchi methods Nucleic Acids Res 22 1994 3801 3805
13. C. Jeney, O. Dobay, A. Lengyel, E. Adam, and I. Nasz Taguchi optimization of ELISA procedures J Immunol Methods 223 1999 137 146
14. G.J. Burch, C.H. Ferguson, G. Catwright, and F.Y. Kwong Application of Taguchi experimental design to the optimization of baculovirus expression system Biochem Soc Trans 23 1995 107S
15. H. Kallel, H. Zairi, S. Rourou, M. Essafi, R. Barbouche, and K. Dellagi use of Taguchi's methods as a basis to optimize hybridoma cell line growth and antibofd production in a spinner flask Cytotechnology 39 2002 9 14
16. X. Shi, T. Karkut, M. Chamankhah, M. Alting-Mees, S.M. Hemmingsen, and D. Hegedus Optimal conditions for the expression of a single-chain antibody (ScFv) gene in Pichia pastoris Protein Expr Purif 28 2003 321 330
17. N.Q. Meinander, M. Jeppson, and M. Sögaard Optimisation of the solubility of the recombinant Itk kinase domain in Escherichia coli. Recombinant protein production with prokaryotic and eukaryotic cells 2000 Kluwer Academic Publishers Dordrecht p.159-169
18. Y. Chen, M. Jin, T. Egborge, G. Coppola, J. Andre, and D.H. Calhoun Expression and characterization of glycosylated and catalytically active recombinant human α-galactosidase A produced in Pichia pastoris Protein Expr Purif 20 2000 472 484
19. K. Sreekrishna, R.G. Brankamp, K.E. Kropp, D.T. Blankenship, J.T. Tsay, and P.L. Smith Strategies for optimal synthesis and secretion of heterologous proteins in the methylotrophic yeast Pichia pastoris Gene 190 1997 55 62
20. B.H. Chung, and K.S. Park Signe approach to reducing proteolysis during secretory production of human parathyroid hormone in Saccharomyces cerevisiae Biotechnol Bioeng 57 1997 245 249
21. A.K. Chauhan, D. Arora, and N. Khanna A novel feeding strategy for enhanced protein production by fed-batch fermentation in recombinant Pichia pastoris Process Biochem 34 1999 139 145
22. C. Marty, P. Scheidegger, and K. Ballmer-Hofer Production of functionalised single-chain Fv antibody fragments binding to the ED-B domain of the B-isoform of fibronectin in Pichia pastoris Protein Expr Purif 21 2001 156 164
23. S. Hellwig, F. Emde, N.P. Raven, M. Henke, P. Van Der Logt, and R. Fischer Analysis of single-chain antibody production in Pichia pastoris using on-line methanol control in fed-batch and mixed-feed fermentations Biotechnol Bioeng 74 2001 344 352